Meeting Banner
Abstract #1638

Axillary MRI relaxometry as a tool for assessing risk of lymphedema development

Paula M.C. Donahue1, Rachelle M.C. Crescenzi2, and Manus Donahue2

1Physical Medicine and Rehabilitation, Vanderbilt University Medical Center, Nashville, TN, United States, 2Radiology, Vanderbilt University Medical Center, Nashville, TN, United States

We applied a novel application of T2 mapping in a longitudinal study to evaluate whether MRI relaxometry may hold more potential than current measures for portending breast-cancer-treatment-related-lymphedema (BCRL) progression. Baseline biophysical and T2 measurements were performed in patients following lymph node removal. Patients were then monitored for BCRL progression (duration=two years). Baseline descriptive (age, BMI, number of nodes removed) and biophysical (bioimpedance, tissue dielectric, and arm volume) measures did not discriminate between patients who did vs. did not progress, yet baseline T2 was regionally elevated in those who progressed. MRI relaxometry may serve as a tool to identify BCRL risk.

This abstract and the presentation materials are available to members only; a login is required.

Join Here